Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Clearbridge Health Limited (1H3)

  • SEC News
  • June 16, 2025, 09:56 UTC
  • 1

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Becoming a Substantial Shareholder - Wong Kong Leong

Comment Full text

Top Glove Corporation BHD (BVA)

  • SEC News
  • June 16, 2025, 09:52 UTC
  • 1

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

Comment Full text

Clearbridge Health Limited (1H3)

  • SEC News
  • June 16, 2025, 09:51 UTC
  • 1

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Cessation of Substantial Shareholder - Ong Choon Yi

Comment Full text

IHH Healthcare Berhad (Q0F)

  • SEC News
  • June 16, 2025, 09:29 UTC
  • 1

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Comment Full text

Beverly JCG Ltd. (VFP)

  • SEC News
  • June 15, 2025, 23:39 UTC
  • 7

General Announcement: Sponsors Statement

Comment Full text

Beverly JCG Ltd. (VFP)

  • SEC News
  • June 15, 2025, 23:34 UTC
  • 4

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt

Comment Full text

Cordlife Group Limited (P8A)

  • SEC News
  • June 15, 2025, 23:31 UTC
  • 5

General Announcement: Voluntary Conditional Cash Partial Offer - Despatch of Entitlement Notification Letter

Comment Full text

Beverly JCG Ltd. (VFP)

  • SEC News
  • June 14, 2025, 07:59 UTC
  • 6

Asset Acquisitions and Disposals: Proposed Acquisition of the Second Floor of Tower A of Nobel Healthcare Park

Comment Full text

Novavax Inc (NVAX)

  • SEC News
  • June 14, 2025, 01:42 UTC
  • 6

New Form 4 - NOVAVAX INC Filed: 2025-06-13 AccNo: 0001593968-25-000760 Size: 6 KB

Comment Full text

Vanda Pharmaceuticals Inc (VNDA)

  • SEC News
  • June 14, 2025, 01:41 UTC
  • 3

New Form 144 - Vanda Pharmaceuticals Inc. Filed: 2025-06-13 AccNo: 0000950170-25-086506 Size: 5 KB

Comment Full text
  • Previous
  • 67
  • 68
  • 69
  • 70
  • 71
  • Next

Search

News categories

  • Technical Exchange News(9358)
  • Event(407)
  • SEC News(152579)
  • FDA Approval(8724)
  • Company Report(721)
  • Business News(104284)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin